Urimon's Start-up Pitch at Health~Holland Global Investor Forum 2026
Early detection through non-invasive diagnostics can support a shift toward more proactive healthcare. At this year's Global Investor Forum - Innovation for Health conference, Hein van Es, CCO of URIMON, pitched their multi-disease early warning system based on urinary microRNA profiling to the audience. Watch the video to discover the technology.
URIMON is a multi-disease early warning system based on periodic urinary microRNA profiling. The platform enables non-invasive, early detection of cancer and cardiovascular diseases. Its mission is to shift healthcare from reactive to proactive—extending healthy years for individuals, improving efficiency for healthcare professionals, and reducing costs for stakeholders.
Are you also interested to pitch your company at the next edition of Health~Holland Global Investor Forum and Innovation for Health on 10-11 March 2027 in Utrecht, the Netherlands? Then sign up for the event newsletter to stay informed.
